Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model

類似資料

• Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
  著者:: Berger, Carolina, 等
  出版事項: (2014)
• Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T-cells
  著者:: Hudecek, Michael, 等
  出版事項: (2013)
• Adoptive Therapy with Chimeric Antigen Receptor Modified T Cells of Defined Subset Composition
  著者:: Riddell, Stanley R., 等
  出版事項: (2014)
• The non-signaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity
  著者:: Hudecek, Michael, 等
  出版事項: (2014)
• The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
  著者:: Hudecek, Michael, 等
  出版事項: (2010)